Skip to main content
Log in

Fate of emepronium in man in relation to its pharmacological effects

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

After oral administration of14C-labelled emepronium (150 mg) to two subjects, 1.8 and 3.9% of the radioactivity were recovered from the urine within 24 h, of which 50 and 56% respectively, were excreted during the first 6 h. 23 to 35% of the radioactivity in the urine consisted of emepronium metabolites. 25 mg of the cold compound was injected i.m. in 4 subjects; about 31% was excreted in the urine and about 45% in the faeces within 3 days, probably indicating extensive biliary excretion of unaltered drug. The half-life of emepronium in serum ranged from 1.5 to 2.25 h. The near point of accommodation, salivation and heart rate were compared with the serum concentration of emepronium in a randomized cross-over study in 4 subjects. The heart rate was increased significantly at serum concentrations of about 450 ng/ml, and the secretion of saliva was markedly decreased at about 250 ng/ml. The near point was affected only at the highest serum concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Eksborg, S., Persson, B.-A., Vessman, J., Enell, B.: Determination of a quaternary ammonium compound, emepronium bromide (Cetiprin®) in human urine by an ion pair extraction method. J. pharm. Sci.60, 475–477 (1971)

    Google Scholar 

  • Gröningsson, K., Hammar, C-G., Molin, L., Vessman, J.: unpublished (1972)

  • Hansson, E., Schmiterlöw, C.G.: Biological fate of14C-labelled ethyl (3.3-diphenyl-l-methyl-propyl) dimethylammoniumbromide, Cetiprin®, a monoquaternary ammonium compound. Acta Pharmacol. (Kbh.)18, 183–190 (1961)

    Google Scholar 

  • Sundwall, A., Uthne, K., Vessman, J.: Metabolic disposition of emepronium in the dog with a note on the relationship between plasma concentration and effect. Acta pharmacol. (Kbh.)29, 385–401 (1971)

    Google Scholar 

  • Vessman, J., Strömberg, S., Rietz, G.: Gas chromatography and electron capture detection of benzophenone formed by chromic acid oxidation. II. Determination of emepronium (Cetiprin®) a quaternary ammonium compound in serum. Acta pharm. suecica7, 363–372 (1970)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sundwall, A., Vessman, J. & Strindberg, B. Fate of emepronium in man in relation to its pharmacological effects. Eur J Clin Pharmacol 6, 191–195 (1973). https://doi.org/10.1007/BF00558285

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558285

Key words

Navigation